Fetzima is a drug that is classified under serotonin and norepinephrine reuptake inhibitor antidepressant (SNRI).Fetzimaworks by balancing the brain chemicals that cause depression. Fetzima is mainly used in the treatment of major depressive disorder. Fetzima capsules are only intended for oral use only. The active ingredient in this drug is levomilnacipran hydrochloride.
Fetzima is a drug used in the treatment of major depressive disorder (MDD). The medicine may also be used for purposes not listed in this guide, at the discretion of the prescriber.
The active ingredient of Fetzima – levomilnacipran – is used because it belongs to the serotonin-norepinephrine reuptake inhibitor (SNRI) class of medicines, meaning it works to increase the availability of these two neurotransmitters in nerve terminals. Greater serotonin and norepinephrine concentrations are associated with enhanced mood.
Fetzima is associated with its own range of potential side effects. Among these include increased sweating, vision changes, nausea, vomiting, constipation, and elevated heart rate. Patients may also experience more severe side effects such as seizures, painful urination, and chest pain.